Novo Nordisk  

Eye Damage

Detection and surveillance

Detection and surveillance of eye problems are a routine part of Annual Review

Organize a recall system to ensure it occurs regularly for every individual

Measure or assess yearly :
visual acuity ( glasses or pinhole )
the lens and vitreous ( ophthalmoscopy )
the retina ( dilated pupils, retinal photography or skilled ophthalmoscopy )
related factors ( smoking / blood pressure )

Reassess after shorter interval (3-6 mo) if:
pregnant ( see also : Pregnancy and contraception in Women with Type 2 Diabetes )
new or progressive early or moderate non-proliferative retinopathy
blood glucose control recently improved in people with retinopathy
Eye disease management

Refer to ophthalmologist if :
severe non-proliferative retinopathy
proliferative retinopathy
macular oedema or exudative maculopathy
visual disability from cataract
unexplained deterioration of visual acuity
other eye disease of visual significance
unrecognized eye lesions

Review and intensify management of :
diabetic kidney disease
blood pressure ( target <140/85 mmHg )
blood glucose control
blood lipid control ( if hard exudates )
smoking

Attend to the psychological and social aspects of visual impairment where it develops

The primary management of diabetic eye disease is by careful attention to blood glucose control targets from the time of diagnosis

 

Foot Problems

 

IDF Guidelines to Type 2 diabetes
Click here for 'Topic Finder'

Click here for 'Diagnose and classify hyperglycaemic states'
Click here for 'Ensure effective delivery of care'
Click here for 'Promote effective self-care through education'
Click here for 'Control blood glucose, blood lipids, blood pressure'
Detect and manage diabetes complications
Ischaemic Heart Disease
Kidney Damage
Eye Damage
Foot Problems
Nerve Damage
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page